Guilin Sanjin Pharmaceutical Co Ltd

002275
stockHealthcarePharmaceuticals
$6/day into 002275 since 2015 would be worth $18,152 today — 1.1× the money.
Try your own number →

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache capsule, compound panax notoginseng stomach pain tablets, Sanqi xueshangning capsules, Sanqi xueshangning powder, compound luo han guo qing fei granules, compound luo han guo lung clearing syrup, compound red root tablets, Shuanghu zhongtongning, liver and kidney tonic granules, and jade leaf detoxification granules. Its products are used in various therapeutic areas, such as urinary system disease, oral and throat, cardiovascular and cerebrovascular disease, neurological diseases, respiratory disease, digestive system disease, internal medicine, musculoskeletal system diseases, and tonic drugs. Guilin Sanjin Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of 002275-SZ would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2009) — listing
$28,427
1.2×
$41,903
1.2×
Year 6 (2014)
$19,912
1.1×
$29,328
1.1×
Year 11 (2019)
$11,985
1.1×
$17,686
1.1×
Year 16 (2024)
$3,444
1.0×
$5,157
1.0×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with 002275

For illustration only — not investment advice. Past performance is not indicative of future results.